Mind Medicine Inc [MNMD] stock prices are down -0.27% to $9.40 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MNMD shares have gain 18.47% over the last week, with a monthly amount glided 29.23%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Mind Medicine Inc [NASDAQ: MNMD] stock has seen the most recent analyst activity on July 24, 2024, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $36. Previously, Robert W. Baird started tracking the stock with Outperform rating on May 29, 2024, and set its price target to $27. On April 15, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $20 on the stock. Canaccord Genuity started tracking the stock assigning a Buy rating and suggested a price target of $9 on December 05, 2023. RBC Capital Mkts started tracking with a Outperform rating for this stock on November 16, 2022, and assigned it a price target of $5. In a note dated August 26, 2022, Oppenheimer initiated an Outperform rating and provided a target price of $3.50 on this stock.
The stock price of Mind Medicine Inc [MNMD] has been fluctuating between $2.41 and $12.22 over the past year. Currently, Wall Street analysts expect the stock to reach $21 within the next 12 months. Mind Medicine Inc [NASDAQ: MNMD] shares were valued at $9.40 at the most recent close of the market. An investor can expect a potential return of 123.4% based on the average MNMD price forecast.
Analyzing the MNMD fundamentals
Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -19.68%, Pretax Profit Margin comes in at -25.9%, and Net Profit Margin reading is -25.9%. To continue investigating profitability, this company’s Return on Assets is posted at -0.45, Equity is -1.05 and Total Capital is -0.45. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.23 points at the first support level, and at 9.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.70, and for the 2nd resistance point, it is at 10.00.
Ratios To Look Out For
It’s worth pointing out that Mind Medicine Inc [NASDAQ:MNMD]’s Current Ratio is 3.91. Also, the Quick Ratio is 3.91, while the Cash Ratio stands at 3.87.
Transactions by insiders
Recent insider trading involved Sullivan Mark, Chief Legal Officer, that happened on Jun 25 ’24 when 17854.0 shares were sold. Chief Executive Officer, Barrow Robert completed a deal on Jun 25 ’24 to sell 15659.0 shares. Meanwhile, Chief Medical Officer Karlin Dan sold 6925.0 shares on Jun 25 ’24.
